China Sky One Medical announced that production has started at the Peng Lai Jin Chuang Company facility. China Sky One finalized the acquisition of Jin Chuang last month, paying $7.1 million in cash and stock to gain control of the company. Jin Chuang represents an unusual situation because it boasted a portfolio of twenty approved drugs and was building a manufacturing plant, but the company had not yet begun to market its drugs. More details...

Stock Symbol:  (NASDAQ: CSKI)